News
Dr. Jeremy Levin, former CEO of Teva Pharmaceuticals and a prominent figure in the global biotech industry. (photo credit: Ovid) Dr. Jeremy Levin, former CEO of Teva Pharmaceuticals and a ...
These survey results were presented by Teva as part of a large set of schizophrenia data at the SIRS 2025, taking place from March 29 to April 2 in Chicago (Teva’s press release). (De novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results